BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 11355589)

  • 1. Efficacy of Traditional Chinese Medicine in Treatment and Prophylaxis of Radiation-Induced Oral Mucositis in Patients Receiving Radiotherapy: A Randomized Controlled Trial.
    Wang C; Wang P; Ouyang H; Wang J; Sun L; Li Y; Liu D; Jiang Z; Wang B; Pan Z
    Integr Cancer Ther; 2018 Jun; 17(2):444-450. PubMed ID: 28870095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy and applicability of natural products in the treatment and prevention of radiotherapy-induced oral mucositis: A systematic review.
    Zhang W; Fan L; Xie Y; Gao T; Zeng J
    PLoS One; 2024; 19(5):e0303988. PubMed ID: 38781255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons of successful and failed Phase III trials of drugs and biologicals tested for mitigation of oral mucositis in patients being treated with radiotherapy with or without concomitant chemotherapy for cancers of the head and neck.
    Liang L; Sonis ST
    Drug Dev Res; 2024 May; 85(3):e22188. PubMed ID: 38678547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periodontal Disease - A Late Complication of Head and Neck Cancer Radiotherapy.
    Brandt E; Keskin M; Räisänen IT; Mäkitie A; Pätilä T; Sorsa T; Gupta S
    Cancer Control; 2024; 31():10732748241255845. PubMed ID: 38760005
    [No Abstract]   [Full Text] [Related]  

  • 5. Comment on prospective comparison of acute severe toxicities between smokers and non-smokers during radiotherapy for head and neck cancers.
    Topkan E; Somay E; Bascil S; Selek U
    Oral Oncol; 2024 Aug; 155():106898. PubMed ID: 38880008
    [No Abstract]   [Full Text] [Related]  

  • 6. RE: Pharyngeal Constrictor Muscle Sparing in Head and Neck Radiotherapy.
    Paetkau O; Weppler S; Kwok J; Quon HC; Gomes da Rocha C; Smith W; Tchistiakova E; Kirkby C
    Clin Oncol (R Coll Radiol); 2024 Jul; 36(7):e240-e241. PubMed ID: 38644087
    [No Abstract]   [Full Text] [Related]  

  • 7. Author Response: Radiotherapy Increases aMMP-8-Levels and Neutrophil/Lymphocyte Ratio Rapidly in Head and Neck Cancer Patients: A Pilot Study.
    Brandt E; Keskin M; Tervahartiala T; Yılmaz M; Harmankaya İ; Karaçetin D; İpek T; Kahraman Gürsoy U; Gupta S; Räisänen IT; Hagström J; Rautava J; Sorsa T
    Cancer Control; 2023; 30():10732748231187282. PubMed ID: 37578938
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current status of prevention and management of radiation-induced xerostomia].
    Ma DY; Qiu WL; Zhang CP
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Feb; 45(2):121-3. PubMed ID: 20368009
    [No Abstract]   [Full Text] [Related]  

  • 9. Rationale for integrating high-dose rate intraoperative radiation (HDR-IORT) and postoperative external beam radiation with subcutaneous amifostine for the management of stage III/IV head and neck cancer.
    Hu K; Ship JA; Harrison LB
    Semin Oncol; 2003 Dec; 30(6 Suppl 18):40-8. PubMed ID: 14727239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comments on five clinical trials concerning radiotherapy-induced mucositis in patients with head and neck neoplasms].
    Noël G; Mazeron JJ
    Cancer Radiother; 2001 Apr; 5(2):202-4. PubMed ID: 11355589
    [No Abstract]   [Full Text] [Related]  

  • 11. Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer.
    Antonadou D; Pepelassi M; Synodinou M; Puglisi M; Throuvalas N
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):739-47. PubMed ID: 11849797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer.
    Brizel DM; Wasserman TH; Henke M; Strnad V; Rudat V; Monnier A; Eschwege F; Zhang J; Russell L; Oster W; Sauer R
    J Clin Oncol; 2000 Oct; 18(19):3339-45. PubMed ID: 11013273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comment on: Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: a prospective randomized study.
    Kilic D; Akcali Z
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1373-4. PubMed ID: 11503611
    [No Abstract]   [Full Text] [Related]  

  • 14. Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: a prospective randomized study.
    Makkonen TA; Minn H; Jekunen A; Vilja P; Tuominen J; Joensuu H
    Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):525-34. PubMed ID: 10701730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of granulocyte-macrophage colony-stimulating factor and sucralfate mouthwashes in the prevention of radiation-induced mucositis: a double-blind prospective randomized phase III study.
    Saarilahti K; Kajanti M; Joensuu T; Kouri M; Joensuu H
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):479-85. PubMed ID: 12243825
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.